<- Go Home
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.
Market Cap
$510.1M
Volume
999.4K
Cash and Equivalents
$616.2M
EBITDA
-$477.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$176.4M
Profit Margin
80.94%
52 Week High
$75.20
52 Week Low
$5.26
Dividend
N/A
Price / Book Value
0.64
Price / Earnings
-0.75
Price / Tangible Book Value
0.71
Enterprise Value
$339.5M
Enterprise Value / EBITDA
-0.86
Operating Income
-$538.6M
Return on Equity
-63.51%
Return on Assets
-19.19
Cash and Short Term Investments
$616.2M
Debt
$445.6M
Equity
$797.9M
Revenue
$218.0M
Unlevered FCF
-$195.7M
Sector
Chemicals
Category
N/A
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick Premium